Compensation Failure as the Mechanism of Psychosis in 22q11.2 Deletion Syndrome: A Falsifiable Model
Year: 2026
Type: article
Abstract: The 22q11.2 deletion raises psychosis risk roughly twentyfold, yet most carriers never become psychotic. That gap, not the deletion’s biology, is the explanandum, and most of the cellular literature cannot address it: it compares carriers who have schizophrenia with healthy controls, so what it identifies belongs to the combined deletion-and-illness group and cannot be assigned to the deletion alone. This article proposes that the deleted genes with demonstrated neural phenotypes are dosage-limiting for rates, gains and throughputs rather than for structures, so that hemizygosity narrows the range over which a controlled variable can be corrected. The predicted phenotype is bidirectional instability of set points, which is what is observed: connectivity is in surplus before puberty and in deficit after it in deletion mice and in carriers; synaptic transcripts rise while presynaptic proteins fall; neurons are more excitable while their evoked calcium transients are smaller. The model holds that every carrier compensates, and states itself in six separately defined quantities, each with a proposed measurement or proxy — demand, intrinsic capacity, effort, effective capacity, output and reserve — so that its predictions can differ in sign between them and cannot be averaged into one. Psychosis is placed where the rising demand of adolescent remodeling crosses a falling capacity, with the timing set by regulatory trajectories. The sharpest consequence inverts the usual case-control logic: on compensatory effort the protected carrier should be abnormal beyond controls, not normal, and the one cellular study to have measured compensatory-effort variables in carriers with and without schizophrenia reports that ordering. Because the state is an imbalance rather than accumulated damage, positive symptoms should remit while negative symptoms and functional impairment persist, and they do. Dopamine is placed as a downstream compensator with a perceptual cost rather than a final common pathway. Four prespecified programs state what would falsify the model, with evidence for, evidence against, and inconclusive outcomes defined in advance.
Author: Moore, Tyler
Institution: University of Pennsylvania
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225864072
